CVS Health company headlines, earnings, strategy, leadership, and market-moving business updates.
Market data may be delayed. For informational purposes only. Not investment advice.
The retailer and insurer said it is redesigning the way eligible adults can get clinical care, understand medication costs, and receive ongoing support for GLP-1 drug treatment.
THE APEX TIMES
THE APEX TIMES
Wall Street estimates and companywide momentum will be tested when CVS Health reports second-quarter results, as attention centers on Aetna-driven efforts and performance across its major operations.
THE APEX TIMES
A fresh wave of earnings-related talk and continued attention to store growth are bringing CVS Health back into investor spotlights, with the shares trading around the mid-$100s and the debate centered on how much good news is already priced in.
THE APEX TIMES
A new Yahoo Finance review points to a favorable average brokerage recommendation for CVS Health, while also questioning whether the popular announcement truly captures what matters for investors.
THE APEX TIMES
A recent market note on CVS Health’s second-quarter results says investors are looking beyond headline earnings, turning attention to projections for several “key metrics” tied to the quarter ended in June 2026.
THE APEX TIMES
The Woonsocket, Rhode Island-based health insurer and pharmacy retailer says its customer experience performance was recognized with an overall top honor plus four separate Gold Awards at the 2026 U.S. Customer Experience Awards.
THE APEX TIMES
CVS Health said it was recognized as the Overall Winner at the 2026 US Customer Experience Awards and received four gold awards, an acknowledgment the company frames as a measure of customer service performance across its health retail and care operations.
THE APEX TIMES
In a company-distributed wellness post republished via Yahoo Finance, CVS Health urged shoppers to treat sunscreen SPF as an everyday routine and challenged common misconceptions about how sun protection works.
THE APEX TIMES
An analyst note circulated by Yahoo Finance points to improving earnings indicators for CVS Health alongside peers Cardinal Health, Humana and ACADIA Pharmaceuticals, even as profitability remains under pressure in parts of the healthcare supply chain and managed care.
